Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Fish and Richardson
UBS
Fuji
QuintilesIMS
Express Scripts
Mallinckrodt
AstraZeneca
Federal Trade Commission
Argus Health

Generated: August 20, 2017

DrugPatentWatch Database Preview

ZOLMITRIPTAN Drug Profile

« Back to Dashboard

Which patents cover Zolmitriptan, and when can generic versions of Zolmitriptan launch?

Zolmitriptan is a drug marketed by Aurobindo Pharma Ltd, Alembic Pharms Ltd, Macleods Pharms Ltd, Ajanta Pharma Ltd, Jubilant Generics, Glenmark Generics, Teva Pharms Usa, Pld Acquisitions Llc, Appco Pharma Llc, Apotex Inc, Sun Pharma Global, Invagen Pharms, Mylan Pharms Inc, and Zydus Pharms Usa Inc. and is included in nineteen NDAs.

The generic ingredient in ZOLMITRIPTAN is zolmitriptan. There are twenty drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.

Summary for Tradename: ZOLMITRIPTAN

Patents:0
Applicants:14
NDAs:19
Suppliers / Packagers: see list15
Bulk Api Vendors: see list54
Clinical Trials: see list14
Patent Applications: see list2,582
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZOLMITRIPTAN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Generics
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL202279-002Nov 20, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL202078-002May 14, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Invagen Pharms
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL204284-001Apr 9, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Generics
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL201779-001May 14, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL207021-001May 11, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Cipla
McKinsey
AstraZeneca
Teva
Johnson and Johnson
Chubb
McKesson
Colorcon
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot